Fragile X Clinical Trial of PDE4D Inhibitor скачать в хорошем качестве

Fragile X Clinical Trial of PDE4D Inhibitor

Dr. Elizabeth Berry-Kravis of Rush University Medical Center is conducting a clinical trial of an investigational new drug for men ages 18-45 with Fragile X syndrome. Dr. Berry-Kravis describes what's involved in this trial and what it offers for future treatment prospects. The study is funded by FRAXA Research Foundation with additional support from Tetra Discovery Partners and the Pierce Family Fragile X Foundation. Learn More about this Fragile X Clinical Trial: https://www.fraxa.org/fragile-x-clini... Enrollment Information Melissa R Baer, MS, CCRC (312) 563-6636 [email protected] FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. We directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments. Treatments for Fragile X are likely to help people affected by autism, Alzheimer’s, and other brain disorders. To learn more about FRAXA's Fragile X Syndrome research, to get involved with Fragile X awareness and events or to donate to FRAXA research, visit FRAXA.org Let's Connect: LinkedIn:   / fraxa-research-foundation   Instagram:   / fraxaresearch   Twitter:   / fraxaresearch   Facebook:   / fraxaresearch   Website: https://www.FRAXA.org